SUPPLEMENTARY FINANCIAL STATEMENT INFORMATION

12 Months Ended

Dec. 31, 2025

Organization, Consolidation and Presentation of Financial Statements [Abstract]

SUPPLEMENTARY FINANCIAL STATEMENT INFORMATION

NOTE 11 - SUPPLEMENTARY FINANCIAL STATEMENT INFORMATION:

Balance sheets:

a Inventory:

	December 31,
	2025		2024
	($ in thousands)
Finished goods	$	352	$	18
Work in process		930		638
Raw materials and supplies		2,114		1,914
	$	3,396	$	2,570

b Accounts payable and accruals-other:

	December 31,
	2025		2024
	($ in thousands)
Employees and employee institutions	$	4,925	$	3,414
Accrued vacation and recreation pay		430		369
Accrued expenses		1,545		1,325
Clinical trial accrual		1,155		519
Current Operating lease liabilities		1,066		542
Other		336		255
	$	9,457	$	6,424